On May 7, 2021, the inactivated COVID-19 vaccines developed and produced by Sinopharm CNBG's Beijing Institute of Biological Products received emergency use authorization from the World Health Organization.

2021年5月7日,国药集团中国生物北京生物制品研究所研发生产的新型冠状病毒灭活疫苗(Vero细胞),获得世卫组织紧急使用授权。.jpg

Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing

Postcode: 100191

Tel: 86-10-82287727

Fax: 86-10-62033332

Copyright ©  China National Pharmaceutical Group Co Ltd. All rights reserved. Presented by China Daily. 京公网安备 11040102700104号 京ICP备:14023670号-1
On May 7, 2021, the inactivated COVID-19 vaccines developed and produced by Sinopharm CNBG's Beijing Institute of Biological Products received emergency use authorization from the World Health Organization.

2021年5月7日,国药集团中国生物北京生物制品研究所研发生产的新型冠状病毒灭活疫苗(Vero细胞),获得世卫组织紧急使用授权。.jpg

Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing

Postcode: 100191 Tel: 86-10-82287727

Fax: 86-10-62033332

Copyright ©  China National Pharmaceutical Group Co Ltd.
All rights reserved. Presented by China Daily. 京公网安备 11040102700104号
京ICP备:14023670号-1